Commack, NY17 Active Studies

Interstitial Cystitis Clinical Trials in Commack, NY

Find 17 actively recruiting interstitial cystitis clinical trials in Commack, NY. Connect with local research sites and explore new treatment options.

17
Active Trials
2
Sponsors
1,436
Enrolling

Recruiting Interstitial Cystitis Studies in Commack

RecruitingCommack, NYNCT05897320

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants....

315 participants
H. Lundbeck A/S
View Study Details
RecruitingCommack, NYNCT03824483

Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

The purpose of this study is to determine the rate of minimum residual disease (MRD) negative response (i.e. the rate of no evidence of disease) of the study drugs, zanubrutinib, obinutuzumab, and ven...

230 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT06099769

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor...

201 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT03808337

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

This study is being done to determine if stereotactic body radiotherapy (SBRT) when delivered to all sites of disease in participants with 1-5 metastases will increase the length of time before partic...

145 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT04419519

Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

This study will find out whether people with CLL or SLL who have received treatment with venetoclax, either alone or in combination with another drug, and who are found to be MRD-negative, can stop tr...

80 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT05389293

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

The purpose of this study is to find out if mosunetuzumab is an effective treatment in people with follicular lymphoma that was recently diagnosed and have not yet received any treatments for their di...

76 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT05851924

A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

The researchers are doing this study to find out whether using the chemotherapy regimen NALIRIFOX in combination with ablative dose radiation therapy (AD-XRT) and the standard chemotherapy drug capeci...

60 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT06168812

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

The purpose of this study is to find out how effective and safe glipizide is for lowering blood sugar in people with pancreatic cancer....

40 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT05787561

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

This study will test if Avutometinib (VS-6766) in combination with Defactinib is an effective treatment for advanced or recurrent mesonephric gynecologic cancer....

40 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT05787574

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

The researchers are doing this study to find out whether emapalumab or a combination of fludarabine and dexamethasone are effective in preparing people with a primary immune regulatory disorder (PIRD)...

39 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT06411821

Ulixertinib in People With Histiocytic Neoplasms

The researchers are doing this study is to find out whether ulixertinib is an effective and safe treatment for people with histiocytic neoplasms....

38 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT06251973

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

Participants will receive study treatment with agenT-797, botensilimab, balstilimab, ramucirumab, and paclitaxel. When participants start each agent will depend on how their disease is affecting them....

37 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT05354570

A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest

The researchers are doing this study to find out whether hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) is a safe treatment that causes few or mild side effects in people with pl...

36 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT06891560

A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma

The purpose of this study is to find out whether enfortumab vedotin is an effective and safe treatment for people with adenoid cystic carcinoma (ACC)....

34 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT05010031

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

This study will test whether reduced-dose radiotherapy is an effective treatment for metastatic tumors with an ATM mutation. The researchers want to find the lowest dose of radiation that would still ...

29 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT05736419

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Hematopoietic Cell Transplantation/HCT involves receiving healthy blood-forming cells (stem cells) from a donor to replace the diseased or damaged cells in participants' bone marrow. The researchers t...

24 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingCommack, NYNCT06066333

Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

The purpose of this study is to determine whether pembrolizumab given after standard ablative Radiotherapy is a safe treatment that causes few or mild side effects in people with advanced Adrenocortic...

12 participants
Memorial Sloan Kettering Cancer Center
View Study Details

About Interstitial Cystitis Clinical Trials in Commack

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 17 interstitial cystitis clinical trials recruiting participants in Commack, NY. These studies are seeking a combined 1,436 participants. Research is being sponsored by H. Lundbeck A/S, Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Commack — FAQ

Are there interstitial cystitis clinical trials in Commack?

Yes, there are 17 interstitial cystitis clinical trials currently recruiting in Commack, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Commack?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you about next steps.

Are clinical trials in Commack free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Commack studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 17 active trials in Commack are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated March 2, 2026 from ClinicalTrials.gov